• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYHS2300144 二甲双胍恩格列净片(Ⅲ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs(4) Generic Drug 2023-01-16 Jiangsu Deyuan Pharmaceutical Co Ltd view
CYHS2301968 二甲双胍恩格列净片(Ⅲ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs(4) Generic Drug 2023-07-22 Chengdu Shuxi Pharmaceutical Co Ltd view
JYHB2000468 二甲双胍恩格列净片(Ⅲ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2020-04-22 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2020-05-14 view
JYHB2001000 二甲双胍恩格列净片(Ⅲ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2020-07-03 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2020-08-21 view
JYHB2000798 二甲双胍恩格列净片(Ⅲ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2020-06-19 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2020-07-07 view
JYHB2000704 二甲双胍恩格列净片(Ⅲ) empagliflozin;metformin hydrochloride Tablet Chemical Drugs Supplementary Application 2020-06-04 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Filed 2020-06-16 view